Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Molecular Diagnostics (MDx) Point of Care market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to MarkNtel Advisors’ research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth.
Assays are expected to grab the largest market share in the Global Molecular Diagnostics Point of Care market during 2020-25. The assays are uniquely intended for points of care such as hospital critical care units, Specialty clinics, and other healthcare services delivery centers.
North America dominated the Global Mdx Point of Care market in 2019. The same trend is set to prevail during the forecast period. However, the year-on-year growth of Asia-Pacific is set to outperform other geographies during the same period. The region is forecast to grow at a CAGR of around 15.89% during 2020-25, as stated in the MarkNtel Advisors’ research report “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”.
According to MarkNtel Advisors, Abbott Laboratories, Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, and Quidel are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.
Key Questions Answered in the Market Research Report
- What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast, Market Segmentation, Market Shares) of Global Molecular Diagnostics (MDx) Point of Care Market?
- What are the region wise industry size, growth drivers and challenges key market trends?
- What are the key innovations, technology upgrades, opportunities, regulations in the Global Molecular Diagnostics (MDx) Point of Care Market?
- Who are the key competitors or market players and how they perform in Global Molecular Diagnostics (MDx) Point of Care Market on the basis of competitive benchmarking matrix?
- What are the key results derived from the market surveys conducted during the course of Global Molecular Diagnostics (MDx) Point of Care Market study?
Market Outlook, Segmentation and Statistics
- Market Size & Analysis
- Market Share & Analysis
- By Application
- Infectious Diseases
- Oncology
- Hematology
- Prenatal Testing
- Endocrinology
- Others
- By Technology
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Polymerase Chain Reaction (PCR)
- Digital PCR
- Real Time PCR
- Others
- By Product
- By Test-Location
- OTC (Over-the-counter)
- POC (Point-of-care)
- By End-User
- Decentralized Labs
- Hospitals
- Homecare
- Assisted Living Healthcare Facilities
- Others
- By Company
- Revenue Shares
- Strategic Factorial Indexing
- Competitor Placement in MarkNtel Quadrant
- By Region
- North America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- The United States Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Canada Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Mexico Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- South America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Brazil Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Argentina Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Rest of South America Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Europe Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- The UK Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Germany Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- France Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Italy Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Spain Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Rest of Europe Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Middle East & Africa Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- UAE Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Saudi Arabia Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Rest of Middle East & Africa Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Asia-Pacific Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- China Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Japan Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- India Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Australia and New Zealand Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- South Korea Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Rest of Asia Pacific Molecular Diagnostics (MDx) Point of Care Market Size, By Revenues (USD Million), 2015-2025F
- Global Molecular Diagnostics (MDx) Point of Care Market Policies, Regulations, Product Standard
- Global Molecular Diagnostics (MDx) Point of Care Market Intellectual Property Rights Analysis
- Global Molecular Diagnostics (MDx) Point of Care Market Hotspots & Opportunities
- Competition Outlook
- Competitor Wise Growth Strategies
- Company Profiles
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on Global Molecular Diagnostics (MDx) Point of Care Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What would be the growth rate or CAGR of the Global Molecular Diagnostics (MDx) Point of Care Market during 2020-25?
A. The growth rate of the Global Molecular Diagnostics (MDx) Point of Care Market during 2020-25 is forecast to be around 13%
Q. Who are the key competitors or players operating in the Global Molecular Diagnostics (MDx) Point of Care Market?
A. Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, Quidel, etc., are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.
Q. Which end-user segment would emerge as an opportunity area for players in Global Molecular Diagnostics (MDx) Point of Care Market?
A. The hospital segment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which region would emerge as an opportunity area for players in Global Molecular Diagnostics (MDx) Point of Care Market?
A. North America region grabbed a significant market share continues to grow at the highest CAGR, presenting immense opportunities for manufacturers and suppliers of the Global Molecular Diagnostics (MDx) Point of Care Market.
